OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Expanded Access, Aging Populations and Increasing Obesity Levels to Drive Future Growth
出 版 商：GBI Research
出版日期：2012/11/30
頁 數：104頁
文件格式：PDF
價 格：
USD 3,500 (Single-User License)
USD 7,000 (Multi-User License)
USD 10,500 (Global-User License)
USD 7,000 (Multi-User License)
USD 10,500 (Global-User License)
OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Expanded Access, Aging Populations and Increasing Obesity Levels to Drive Future Growth
Summary
GBI Research, the leading business intelligence provider, has released its latest research, “OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Expanded Access, Aging Populations and Increasing Obesity Levels to Drive Future Growth”, which provides insights into the up-and-coming trends of the Over the Counter (OTC) pharmaceutical market by analyzing the trends in population health, healthcare and self-care in seven emerging markets: China, India, Russia, Brazil, Mexico, Indonesia and Turkey.
Six main product categories are covered in the report -
- Cough, cold and allergy treatments
- Analgesics and antipyretics
- Gastrointestinal remedies
- Dermatological products
- Vitamins, minerals and supplements
- Lifestyle OTC products
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
All seven markets are expected to continue growth trends over the period 2011–2018, with China as the fastest growing market with a CAGR of 10%. Consumers within these markets are increasing in affluence and are becoming more informed in terms of health education matters. This has lead to an increase in self-care and in purchases of OTC pharmaceuticals.
The populations of all seven markets are becoming more elderly as healthcare systems and general living conditions are improving, this is a significant driver for the OTC market as the over 60s use the most OTC products, worldwide, of any age group. Obesity is also increasing within these markets, particularly in China. This will drive the growth of the overall OTC market and will act as a specific driver for weight management products that fall under the lifestyle OTC category.
Scope
- The report analyzes trends in population health, healthcare and self-care and uses these trends to inform the future buying habits of the OTC market.
- Current and future trends of major health issues affecting populations within the markets.
- Market forecasts for OTC products for each country.
- OTC market segmentation by six product categories.
- Information on the local regulatory systems of each country.
Reasons to buy
- Understand how the OTC market has developed and is continuing to develop within the featured markets.
- Predict which products are likely to be most successful in the future.
- Gain an understanding of the possible market available for specific products.
- Understand how new products can gain OTC status in the featured markets.
Summary
GBI Research, the leading business intelligence provider, has released its latest research, “OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Expanded Access, Aging Populations and Increasing Obesity Levels to Drive Future Growth”, which provides insights into the up-and-coming trends of the Over the Counter (OTC) pharmaceutical market by analyzing the trends in population health, healthcare and self-care in seven emerging markets: China, India, Russia, Brazil, Mexico, Indonesia and Turkey.
Six main product categories are covered in the report -
- Cough, cold and allergy treatments
- Analgesics and antipyretics
- Gastrointestinal remedies
- Dermatological products
- Vitamins, minerals and supplements
- Lifestyle OTC products
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
All seven markets are expected to continue growth trends over the period 2011–2018, with China as the fastest growing market with a CAGR of 10%. Consumers within these markets are increasing in affluence and are becoming more informed in terms of health education matters. This has lead to an increase in self-care and in purchases of OTC pharmaceuticals.
The populations of all seven markets are becoming more elderly as healthcare systems and general living conditions are improving, this is a significant driver for the OTC market as the over 60s use the most OTC products, worldwide, of any age group. Obesity is also increasing within these markets, particularly in China. This will drive the growth of the overall OTC market and will act as a specific driver for weight management products that fall under the lifestyle OTC category.
Scope
- The report analyzes trends in population health, healthcare and self-care and uses these trends to inform the future buying habits of the OTC market.
- Current and future trends of major health issues affecting populations within the markets.
- Market forecasts for OTC products for each country.
- OTC market segmentation by six product categories.
- Information on the local regulatory systems of each country.
Reasons to buy
- Understand how the OTC market has developed and is continuing to develop within the featured markets.
- Predict which products are likely to be most successful in the future.
- Gain an understanding of the possible market available for specific products.
- Understand how new products can gain OTC status in the featured markets.
1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 7
2 Introduction 9
3 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Overview 10
3.1 Overview 10
3.2 OTC Pharmaceuticals 10
3.3 Rx-to-OTC Switching 10
3.4 Regulation of OTC Pharmaceuticals 11
3.4.1 China 11
3.4.2 India 12
3.4.3 Russia 12
3.4.4 Brazil 13
3.4.5 Mexico 13
3.4.6 Turkey 14
3.4.7 Indonesia 14
4 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Product Types 15
4.1 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Overview 15
4.2 Leading Product Types 15
4.2.1 Cough, Cold and Allergy 15
4.2.2 Analgesics/Antipyretics 15
4.2.3 Gastrointestinal 16
4.2.4 Dermatologicals 16
4.2.5 Vitamins, Minerals and Supplements 17
4.2.6 Lifestyle OTC Products 17
5 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Comparison 18
5.1 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets, 2011-2018 18
5.2 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Market Drivers and Restraints 20
5.3 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets, Forecast Methodology 22
6 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Geographical Breakdown 23
6.1 China 23
6.1.1 Introduction 23
6.1.2 OTC Category Analysis 30
6.1.3 Key Growth Drivers and Restraints 32
6.1.4 OTC Sales Forecast to 2018 33
6.1.5 Recent Developments 34
6.1.6 Outlook 34
6.2 India 35
6.2.1 Introduction 35
6.2.2 OTC Category Analysis 42
6.2.3 Key Growth Drivers and Restraints 43
6.2.4 OTC Sales Forecast to 2018 44
6.2.5 Recent Developments 45
6.2.6 Outlook 45
6.3 Russia 46
6.3.1 Introduction 46
6.3.2 OTC Category Analysis 52
6.3.3 Key Growth Drivers and Restraints 53
6.3.4 OTC Sales Forecast to 2018 54
6.3.5 Recent Developments 55
6.3.6 Outlook 55
6.4 Brazil 56
6.4.1 Introduction 56
6.4.2 OTC Category Analysis 62
6.4.3 Key Growth Drivers and Restraints 63
6.4.4 OTC Sales Forecast to 2018 64
6.4.5 Recent Developments 64
6.4.6 Outlook 65
6.5 Mexico 65
6.5.1 Introduction 65
6.5.2 OTC Category Analysis 71
6.5.3 Key Growth Drivers and Restraints 72
6.5.4 OTC Sales Forecast to 2018 73
6.5.5 Recent Developments 74
6.5.6 Outlook 74
6.6 Turkey 75
6.6.1 Introduction 75
6.6.2 OTC Category Analysis 81
6.6.3 Key Growth Drivers and Restraints 82
6.6.4 OTC Sales Forecast to 2018 83
6.6.5 Recent Developments 84
6.6.6 Outlook 84
6.7 Indonesia 85
6.7.1 Introduction 85
6.7.2 OTC Category Analysis 92
6.7.3 Key Growth Drivers and Restraints 93
6.7.4 OTC Sales Forecast to 2018 94
6.7.5 Recent Developments 95
6.7.6 Outlook 95
7 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Takeaway 96
8 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Appendix 98
8.1 Abbreviations 98
8.2 Sources 98
8.3 Research Methodology 100
8.3.1 Coverage 100
8.3.2 Secondary Research 100
8.3.3 Primary Research 101
8.3.4 Therapeutic Landscape 101
8.3.5 Expert Panel Validation 104
8.4 Contact Us 104
8.5 Disclaimer 104
1.1 List of Tables
Table 1: OTC Market, Seven Emerging Markets, Sales ($bn), 2011-2018 18
Table 2: OTC Market, Seven Emerging Markets, Drivers and Restraints 20
Table 3: OTC Market, Drivers and Restraints, China 32
Table 4: OTC Market, China, Sales ($bn), 2011-2018 33
Table 5: OTC Market, Drivers and Restraints, India 43
Table 6: OTC Market, India, Sales ($bn), 2011-2018 44
Table 7: OTC Market, Drivers and Restraints, Russia 53
Table 8: OTC Market, Russia, Sales ($bn), 2011-2018 54
Table 9: OTC Market, Drivers and Restraints, Brazil 63
Table 10: OTC Market, Brazil, Sales ($bn), 2011-2018 64
Table 11: OTC Market, Drivers and Restraints, Mexico 72
Table 12: OTC Market, Mexico, Sales ($bn), 2011-2018 73
Table 13: OTC Market, Drivers and Restraints, Turkey 82
Table 14: OTC Market, Turkey, Sales ($bn), 2011-2018 83
Table 15: OTC Market, Drivers and Restraints, Indonesia 93
Table 16: OTC Market, Indonesia, Sales ($bn), 2011-2018 94
1.2 List of Figures
Figure 1: OTC Market, Seven Emerging Markets, Sales by Markets ($bn), 2011-2018 18
Figure 2: OTC Market, Seven Emerging Markets, Annual Growth Rates (%), 2011-2018 19
Figure 3: Population Pyramid by Age Class, China, 2010 23
Figure 4: Population > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018 24
Figure 5: Main Causes of Death, China, Ages 0-14, Both Sexes (%), 2008 25
Figure 6: Main Causes of Death, China, Ages 15-59, Both Sexes (%), 2008 26
Figure 7: Main Causes of Death, China, Ages >60, Both Sexes (%), 2008 27
Figure 8: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018 28
Figure 9: OTC Market, China, by Category (Including TCM), Sales (%), 2011 30
Figure 10: OTC Market, China, by Category (Excluding TCM), Sales (%), 2011 30
Figure 11: OTC Market, China, Sales ($bn), 2011-2018 33
Figure 12: Population Pyramid, India, 2010 35
Figure 13: Population > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018 36
Figure 14: Main Causes of Death, India, Ages 0-14, Both Sexes (%), 2008 37
Figure 15: Main Causes of Death, India, Ages 15-59, Both Sexes (%), 2008 38
Figure 16: Main Causes of Death, India, Ages >60, Both Sexes (%), 2008 39
Figure 17: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018 40
Figure 18: OTC Market, India, by Category, Sales (%),2011 42
Figure 19: OTC Market, India, Sales ($bn), 2011-2018 44
Figure 20: Population Pyramid, Russia, 2010 46
Figure 21: Populations > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018 47
Figure 22: Main Causes of Death, Russia, Ages 0-14, Both Sexes (%), 2008 48
Figure 23: Main Causes of Death, Russia, Ages 15-59, Both Sexes (%), 2008 49
Figure 24: Main Causes of Death, Russia, Age >60, Both Sexes (%), 2008 50
Figure 25: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018 51
Figure 26: OTC Market, Russia, by Category, Sales (%), 2011 52
Figure 27: OTC Market, Russia, Sales ($bn), 2011-2018 54
Figure 28: Population Pyramid, Brazil, 2010 56
Figure 29: Population > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018 57
Figure 30: Main Causes of Death, Brazil, Ages 0-14, Both Sexes (%), 2008 58
Figure 31: Main Causes of Death, Brazil, Ages 15-59, Both Sexes (%), 2008 59
Figure 32: Main Causes of Death, Brazil, Ages >60, Both Sexes (%), 2008 60
Figure 33: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018 61
Figure 34: OTC Market, Brazil, by Category, Sales (%), 2011 62
Figure 35: OTC Market, Brazil, Sales ($bn), 2011-2018 64
Figure 36: Population Pyramid, Mexico, 2010 65
Figure 37: Populations > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018 66
Figure 38: Main Causes of Death, Mexico, Ages 0-14, Both Sexes (%), 2008 67
Figure 39: Main Causes of Death, Mexico, Ages 15-59, Both Sexes (%), 2008 68
Figure 40: Main Causes of Death, Mexico, Ages >60, Both Sexes (%), 2008 69
Figure 41: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018 70
Figure 42: OTC Market, Mexico, by Category, Sales (%), 2011 71
Figure 43: OTC Market, Mexico, Sales ($bn), 2011-2018 73
Figure 44: Population Pyramid, Turkey, 2010 75
Figure 45: Population > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018 76
Figure 46: Main Causes of Death, Turkey, Ages 0-14, Both Sexes (%), 2008 77
Figure 47: Main Causes of Death, Turkey, Ages 15-59, Both Sexes (%), 2008 78
Figure 48: Main Causes of Death, Turkey, Ages >60, Both Sexes (%), 2008 79
Figure 49: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018 80
Figure 50: OTC Market, Turkey, by Category, Sales (%), 2011 81
Figure 51: OTC Market, Turkey, Sales ($bn), 2011-2018 83
Figure 52: Population Pyramid, Indonesia, 2010 85
Figure 53: Population > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018 86
Figure 54: Main Causes of Death, Indonesia, Ages 0-14, Both Sexes (%), 2008 87
Figure 55: Main Causes of Death, Indonesia, Ages 15-59, Both Sexes (%), 2008 88
Figure 56: Main Causes of Death, Indonesia, Ages >60, Both Sexes (%), 2008 89
Figure 57: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018 90
Figure 58: OTC Market, Indonesia, by Category (Including TCM), Sales (%), 2011 92
Figure 59: OTC Market, Indonesia, by Category (Excluding TCM), Sales (%), 2011 92
Figure 60: OTC Market, Indonesia, Sales ($bn), 2011-2018 94
Figure 61: GBI Research Market Forecasting Model 103
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 7
2 Introduction 9
3 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Overview 10
3.1 Overview 10
3.2 OTC Pharmaceuticals 10
3.3 Rx-to-OTC Switching 10
3.4 Regulation of OTC Pharmaceuticals 11
3.4.1 China 11
3.4.2 India 12
3.4.3 Russia 12
3.4.4 Brazil 13
3.4.5 Mexico 13
3.4.6 Turkey 14
3.4.7 Indonesia 14
4 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Product Types 15
4.1 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Overview 15
4.2 Leading Product Types 15
4.2.1 Cough, Cold and Allergy 15
4.2.2 Analgesics/Antipyretics 15
4.2.3 Gastrointestinal 16
4.2.4 Dermatologicals 16
4.2.5 Vitamins, Minerals and Supplements 17
4.2.6 Lifestyle OTC Products 17
5 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Comparison 18
5.1 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets, 2011-2018 18
5.2 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Market Drivers and Restraints 20
5.3 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets, Forecast Methodology 22
6 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Geographical Breakdown 23
6.1 China 23
6.1.1 Introduction 23
6.1.2 OTC Category Analysis 30
6.1.3 Key Growth Drivers and Restraints 32
6.1.4 OTC Sales Forecast to 2018 33
6.1.5 Recent Developments 34
6.1.6 Outlook 34
6.2 India 35
6.2.1 Introduction 35
6.2.2 OTC Category Analysis 42
6.2.3 Key Growth Drivers and Restraints 43
6.2.4 OTC Sales Forecast to 2018 44
6.2.5 Recent Developments 45
6.2.6 Outlook 45
6.3 Russia 46
6.3.1 Introduction 46
6.3.2 OTC Category Analysis 52
6.3.3 Key Growth Drivers and Restraints 53
6.3.4 OTC Sales Forecast to 2018 54
6.3.5 Recent Developments 55
6.3.6 Outlook 55
6.4 Brazil 56
6.4.1 Introduction 56
6.4.2 OTC Category Analysis 62
6.4.3 Key Growth Drivers and Restraints 63
6.4.4 OTC Sales Forecast to 2018 64
6.4.5 Recent Developments 64
6.4.6 Outlook 65
6.5 Mexico 65
6.5.1 Introduction 65
6.5.2 OTC Category Analysis 71
6.5.3 Key Growth Drivers and Restraints 72
6.5.4 OTC Sales Forecast to 2018 73
6.5.5 Recent Developments 74
6.5.6 Outlook 74
6.6 Turkey 75
6.6.1 Introduction 75
6.6.2 OTC Category Analysis 81
6.6.3 Key Growth Drivers and Restraints 82
6.6.4 OTC Sales Forecast to 2018 83
6.6.5 Recent Developments 84
6.6.6 Outlook 84
6.7 Indonesia 85
6.7.1 Introduction 85
6.7.2 OTC Category Analysis 92
6.7.3 Key Growth Drivers and Restraints 93
6.7.4 OTC Sales Forecast to 2018 94
6.7.5 Recent Developments 95
6.7.6 Outlook 95
7 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Takeaway 96
8 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Appendix 98
8.1 Abbreviations 98
8.2 Sources 98
8.3 Research Methodology 100
8.3.1 Coverage 100
8.3.2 Secondary Research 100
8.3.3 Primary Research 101
8.3.4 Therapeutic Landscape 101
8.3.5 Expert Panel Validation 104
8.4 Contact Us 104
8.5 Disclaimer 104
1.1 List of Tables
Table 1: OTC Market, Seven Emerging Markets, Sales ($bn), 2011-2018 18
Table 2: OTC Market, Seven Emerging Markets, Drivers and Restraints 20
Table 3: OTC Market, Drivers and Restraints, China 32
Table 4: OTC Market, China, Sales ($bn), 2011-2018 33
Table 5: OTC Market, Drivers and Restraints, India 43
Table 6: OTC Market, India, Sales ($bn), 2011-2018 44
Table 7: OTC Market, Drivers and Restraints, Russia 53
Table 8: OTC Market, Russia, Sales ($bn), 2011-2018 54
Table 9: OTC Market, Drivers and Restraints, Brazil 63
Table 10: OTC Market, Brazil, Sales ($bn), 2011-2018 64
Table 11: OTC Market, Drivers and Restraints, Mexico 72
Table 12: OTC Market, Mexico, Sales ($bn), 2011-2018 73
Table 13: OTC Market, Drivers and Restraints, Turkey 82
Table 14: OTC Market, Turkey, Sales ($bn), 2011-2018 83
Table 15: OTC Market, Drivers and Restraints, Indonesia 93
Table 16: OTC Market, Indonesia, Sales ($bn), 2011-2018 94
1.2 List of Figures
Figure 1: OTC Market, Seven Emerging Markets, Sales by Markets ($bn), 2011-2018 18
Figure 2: OTC Market, Seven Emerging Markets, Annual Growth Rates (%), 2011-2018 19
Figure 3: Population Pyramid by Age Class, China, 2010 23
Figure 4: Population > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018 24
Figure 5: Main Causes of Death, China, Ages 0-14, Both Sexes (%), 2008 25
Figure 6: Main Causes of Death, China, Ages 15-59, Both Sexes (%), 2008 26
Figure 7: Main Causes of Death, China, Ages >60, Both Sexes (%), 2008 27
Figure 8: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018 28
Figure 9: OTC Market, China, by Category (Including TCM), Sales (%), 2011 30
Figure 10: OTC Market, China, by Category (Excluding TCM), Sales (%), 2011 30
Figure 11: OTC Market, China, Sales ($bn), 2011-2018 33
Figure 12: Population Pyramid, India, 2010 35
Figure 13: Population > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018 36
Figure 14: Main Causes of Death, India, Ages 0-14, Both Sexes (%), 2008 37
Figure 15: Main Causes of Death, India, Ages 15-59, Both Sexes (%), 2008 38
Figure 16: Main Causes of Death, India, Ages >60, Both Sexes (%), 2008 39
Figure 17: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018 40
Figure 18: OTC Market, India, by Category, Sales (%),2011 42
Figure 19: OTC Market, India, Sales ($bn), 2011-2018 44
Figure 20: Population Pyramid, Russia, 2010 46
Figure 21: Populations > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018 47
Figure 22: Main Causes of Death, Russia, Ages 0-14, Both Sexes (%), 2008 48
Figure 23: Main Causes of Death, Russia, Ages 15-59, Both Sexes (%), 2008 49
Figure 24: Main Causes of Death, Russia, Age >60, Both Sexes (%), 2008 50
Figure 25: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018 51
Figure 26: OTC Market, Russia, by Category, Sales (%), 2011 52
Figure 27: OTC Market, Russia, Sales ($bn), 2011-2018 54
Figure 28: Population Pyramid, Brazil, 2010 56
Figure 29: Population > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018 57
Figure 30: Main Causes of Death, Brazil, Ages 0-14, Both Sexes (%), 2008 58
Figure 31: Main Causes of Death, Brazil, Ages 15-59, Both Sexes (%), 2008 59
Figure 32: Main Causes of Death, Brazil, Ages >60, Both Sexes (%), 2008 60
Figure 33: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018 61
Figure 34: OTC Market, Brazil, by Category, Sales (%), 2011 62
Figure 35: OTC Market, Brazil, Sales ($bn), 2011-2018 64
Figure 36: Population Pyramid, Mexico, 2010 65
Figure 37: Populations > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018 66
Figure 38: Main Causes of Death, Mexico, Ages 0-14, Both Sexes (%), 2008 67
Figure 39: Main Causes of Death, Mexico, Ages 15-59, Both Sexes (%), 2008 68
Figure 40: Main Causes of Death, Mexico, Ages >60, Both Sexes (%), 2008 69
Figure 41: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018 70
Figure 42: OTC Market, Mexico, by Category, Sales (%), 2011 71
Figure 43: OTC Market, Mexico, Sales ($bn), 2011-2018 73
Figure 44: Population Pyramid, Turkey, 2010 75
Figure 45: Population > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018 76
Figure 46: Main Causes of Death, Turkey, Ages 0-14, Both Sexes (%), 2008 77
Figure 47: Main Causes of Death, Turkey, Ages 15-59, Both Sexes (%), 2008 78
Figure 48: Main Causes of Death, Turkey, Ages >60, Both Sexes (%), 2008 79
Figure 49: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018 80
Figure 50: OTC Market, Turkey, by Category, Sales (%), 2011 81
Figure 51: OTC Market, Turkey, Sales ($bn), 2011-2018 83
Figure 52: Population Pyramid, Indonesia, 2010 85
Figure 53: Population > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018 86
Figure 54: Main Causes of Death, Indonesia, Ages 0-14, Both Sexes (%), 2008 87
Figure 55: Main Causes of Death, Indonesia, Ages 15-59, Both Sexes (%), 2008 88
Figure 56: Main Causes of Death, Indonesia, Ages >60, Both Sexes (%), 2008 89
Figure 57: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018 90
Figure 58: OTC Market, Indonesia, by Category (Including TCM), Sales (%), 2011 92
Figure 59: OTC Market, Indonesia, by Category (Excluding TCM), Sales (%), 2011 92
Figure 60: OTC Market, Indonesia, Sales ($bn), 2011-2018 94
Figure 61: GBI Research Market Forecasting Model 103
